Organization
St. Paul Medical Center
1 abstract
Abstract
A RANDOMIZED, CONTROLLED, SAFETY TRIAL OF ADALIMUMAB (D2E7), A FULLY HUMAN ANTI-TNF MONOCLONAL ANTIBODY, GIVEN TO RA PATIENTS IN COMBINATION WITH STANDARD RHEUMATOLOGIC CARE: THE STAR (SAFETY TRIAL OF ADALIMUMAB IN RHEUMATOID ARTHRITIS) TRIALOrg: Denver Arthritis Clinic, University of California Irvine, Stanford University School of Medicine, St. Paul Medical Center, University of Massachusetts Chan Medical School,